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The nervous system is vulnerable to the effects of certain chemicals and physical conditions
found in the work environment. The activities of an occupational neurologist focus on the
evaluation of patients with neurological disorders caused by occupational or environmental
conditions. When one is making a differential diagnosis in patients with neurlogical disorders, the
possibility of toxic exposure or encounters with physical factors in the workplace must not be
overlooked.
Central to an accurate clinical diagnosis is the patient's history. A diagnosis ofan occupational
or environmental neurological problem requires a careful assessment ofthe clinical abnormalities
and confirmation ofthese disabilities by objective tests such as nerve conduction velocity, evoked
potentials, electroencephalogram, neuropsychological batteries, or nerve biopsy. On the basis of
information about hazards in the workplace, safety standards and environmental and biological
monitoring can be implemented in the workplace to reduce the risks ofundue injury.
Clinical manifestations of headache, memory disturbance, and peripheral neuropathy are
commonly encountered presentations of the effects of occupational hazards. Physicians in
everyday clinical practice must be aware ofthe signs and symptoms associated with exposure to
possible neurotoxins and work methods. Occupational and environmental circumstances must be
explored when evaluating patients with neurologic disorders.
The nervous system is vulnerable to the effects of certain chemicals and physical
conditions found in thework environment. The activitiesofan occupational neurologist
focus on the evaluation ofpatients with neurological disorders caused by occupational
or environmental conditions. When one is making a differential diagnosis in patients
with neurological disorders, the possibility of toxic exposure or encounters with
physical factors in the workplace must not be overlooked.
OCCUPATIONAL HISTORY
Central to an accurate clinical diagnosis is the patient's history. Many problems can
be overlooked or misdiagnosed because the person is not questioned about thejob and
its related hazards. The occupational history should include information about the
person's current occupation, job tasks, place of employment, and dates of attendance
on thatjob. Exposure data are crucial. A checklist ofpotentially neurotoxic substances
used in the work process should be made. A description of personal protective
equipment and how it is used, ifatall, will provide further information about the extent
ofpossible exposure. Questions about previous occupations and hobbies are important,
since exposures encountered in the past may be responsible for the presenting health
problems. Inadvertent exposure may occur from contaminated clothing worn home by
a spouse.
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A diagnosis of an occupational or environmental neurological problem requires a
careful assessment of the clinical abnormalities and confirmation of these disabilities
by objective tests such as nerve conduction velocity, evoked potentials, electroencepha-
logram, neuropsychological batteries, or nerve biopsy. Identification of substances
within the environment by measuring air concentration and identification of the
chemical or its metabolites in the blood, urine, hair, or fingernails establishes the
culpable agent.
It is easy to make a diagnosis of chemical-induced intoxication or entrapment
neuropathy in a patient whose work history and circumstances ofexposure are known
and whose signs and symptoms areconsistent with those reported in similar cases in the
literature. However, when a patient is seen by a physician and a neurologic diagnosis
made in the absence ofa detailed work history, the possible relationship to previous or
current exposures may be overlooked. For example, neurological features suggestive of
Parkinson's disease have been associated with previous exposure to carbon disulfide
[1], carbon monoxide [2], manganese [3], and, more recently, accidental exposure to
N-methyl-4-phenyltetrahydropyridine (MPTP). Although the clinical picture may be
similar to common conditions, recognition ofpotential hazards as the true explanation
for the development of abnormal functioning is the first step and is dependent upon
knowledge of the toxicology of the conditions in and around work areas. The
mechanisms for many neurotoxins are still obscure. On the basis of information about
hazards in the workplace, safety standards and environmental and biological monitor-
ing can be implemented in the workplace to reduce the risks ofundue injury.
CLINICAL MANIFESTATIONS AND SYMPTOMATIC APPROACH
Headache
Despite the vagueness ofthe symptoms, the differential diagnosis ofheadache must
include the effects ofexposure to noxious substances. In various references concerning
hazards in the workplace, headache is listed as a complaint following exposure to metal
fumes and solvent vapors [4]. The source of intoxicant, its molecular form, route of
entry, and dose of exposure all determine the acuteness and severity of the symptoms.
In some instances the mechanism for pain is brain swelling (tin, lead) and, in others,
transient hypoxia or vasodilatation (zinc, tellurium, manganese, and nickel) may
account for the pain that is experienced.
Disturbance ofMemory andBehavior
Subtle changes in mental functioning due to intoxication often go unrecognized
unless looked for, using sophisticated neuropsychological test batteries [5,6]. Toxicity
associated with exposure to lead has been discussed in the literature since ancient
times. In the past, lead poisoning was frequently associated with signs of toxic
encephalopathy and peripheral neuropathy [7]. More stringent controls in the
workplace coupled with government regulations and stricter environmental standards
have led to a decline in cases of industrial lead poisoning. Overt manifestations of
lead-related neurotoxicity, including ataxia, confusion, convulsions, weakness, and
paresthesias ofthe extremities are less often seen. Rather, subtle changes in neurologic
dysfunction, such as disturbances of affect, psychomotor function, and nerve conduc-
tion have been reported among workers whose blood concentrations of lead were
relatively low [8].
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Intoxication with manganese is manifested earliest by neuropsychological distur-
bances, including euphoria, apathy, hallucinations, flight of ideas, compulsivity,
agitation, and verbosity [9,10]. Inorganic mercury poisoning has been known to
produce irritability, poor concentration, memory deficiencies, anxiety, and depression
[11].
Attention is being focused on the possible effects of long-term exposure to various
industrial solvents whose common property is their lipid solubility. Because of their
avidity for fat, the nervous system is a major target organ. Effects ofsolvent exposure
on the central nervous system (CNS) may be manifested as a mental disorder, an
impairment in psychologic functioning, or as nervedamage. The acute, narcotic effects
of solvent exposure have been known for a long time, since many solvents were at one
time used as anesthetic agents. Symptoms resulting from acute exposure to solvents
include feelings of intoxication, difficulty in concentrating, and dizziness [12].
Headache, nausea, and vomiting are also known to occur following exposure. Chronic
neurotoxic effects of solvent exposure are characterized by fatigue, irritability, affect
lability, depression, and short-term memory disturbances [13], as well as impairments
in psychomotor speed, attention, and complex verbal reasoning. This has been referred
to in the literature as a psycho-organicsyndrome, implying damagetoa neural element
or from a biochemical disorder in the brain [12].
Exposure to high concentrations of toluene and trichloroethylene (TCE) can cause
narcosis and anesthesia. Chronic exposure to TCE has been reported to cause losses in
coordination, impairment oftactile senses, intolerance to alcohol, tremor, and anxiety
[14]. Chronic exposure to toluene has been reported to cause fatigue, confusion,
weakness, nervousness, and paresthesia of the skin [15]. Grabski [16] first reported a
man who had encephalopathy secondary to toluene inhalation. Knox and Nelson [17]
documented the residual damage in this same individual 14 years later. A similar
long-term finding was made in a case ofTCE 18 years after acute exposure [18].
Several investigations have shown that workers exposed to solvents for long periods
oftimeexhibit disturbances ofCNS functions. Since an excessofsubjective symptoms,
including headache, fatigue, impaired memory, loss ofappetite, and diffuse chest pain,
were reported by Swedish house painters, Hane and co-workers [19] conducted an
epidemiologic study comparing house painters exposed to solvents with unexposed
industrial workers. The group ofpainters were found to have significantly lower mean
scores on psychological tests measuring intellectual capacity and psychomotor coordi-
nation than the referent subjects. The painters also had significantly lower perfor-
mances than expected on memory and reaction time tests. Knave and his co-workers
[20] found differences between workers exposed for several years to jet fuel and
unexposed referent subjects in tests demanding close attention and high sensory motor
speed. Hanninen and associates [21] found impairments in psychologic performances
as well as personality changes among car painters. These included impairments in
visual and verbal memory, reduction ofemotional reactivity, and poorer performance
on verbal intelligence tests. Seppalainen and Harkonen [22] found an increase in theta
activity on EEG among workers exposed to styrene.
Disturbance ofPeripheral Nerve Function
Certain substances have a toxic effect on the peripheral nervous system. Metal
neurotoxins which produce neuropathy include lead, arsenic, and thallium. Methyl-
butyl-ketone (MBK) and n-hexane are two solvents notorious for causing peripheral
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nerve effects. TCE has a predilection for the trigeminal nerve and has been associated
with motor and sensory losses of the face [14]. Physical factors such as repetitive
manual motions may damage the peripheral nerves from actual external compression
or true entrapment. Complaints of numbness and tingling or weakness are early signs
of peripheral neuropathy, often prompting individuals to seek a neurologist's evalua-
tion. The myelin sheath and/or axon are the targets of neurotoxins. The nature of
pathologic change determines the clinical manifestations ofthe condition.
"Segmental demyelination" is the term used to describe primary destruction of the
myelin sheath with relative sparing of the axon. The process results in slowed nerve
conduction velocities. Characteristically, there is no evidence of muscle denervation,
although atrophy has occurred as a result ofdisuse. Recovery is rapid once remyelina-
tion begins and is usually complete in mild to moderate neuropathies.
Axonal degeneration results from a metabolic imbalance of the entire neuron.
Degeneration of the distal portion of the nerve fiber is evident; degeneration of the
myelin sheath may occur secondarily. Unlike segmental demyelination, nerve conduc-
tion rates are usually normal and distal muscles show stages ofdenervation. Recovery
is slow and incomplete.
Neuropathy Due to Metal Toxins
The toxicity oflead on peripheral nerves has been a topic ofconcern for many years.
Current understanding of lead neuropathy is based upon the physiologic-pathologic
correlations of Fullerton [23], who demonstrated slowing in motor nerve conduction
velocities in the sciatic nerves of guinea pigs fed lead acetate. This disturbance was
observed in myelinated fibers, with large fibers more affected than small fibers. Both
segmental demyelination and axonal degeneration were noted.
The development of clinical features is insidious, occurring after several months of
exposure with increased absorption and accumulation of lead. Numbness and tingling
of the fingers and toes are the initial symptoms, followed by motor weakness. Blood
lead levels and zinc protoporphyrin levels, the hematopoietic indicators of lead
exposure, are elevated. Ofparticular interest is the fact that tissue stores oflead build
up in the liver, muscles, and bones with continued exposure. As a result, autointoxica-
tion can occur even after exposure has ceased, depending upon the exchangeable
fraction oflead in these tissue stores and itsgradual leaching out into the blood system.
Detection at an early stage of neuropathy allows for a significant degree of recovery
from lead neuropathy if exposure is ended and excess lead is removed from the body
tissues by chelation. Weakness, sensory changes, and paresthesia persist if the
combined myelin-axonal degeneration has already occurred.
Clinical manifestations of arsenic neuropathy initially present as losses ofsensation
in the feet and hands. Dysesthesias are common. Position and vibration sensation are
usually impaired, and there is reduced perception topainful stimuli. Motor impairment
is gradual in its onset, involving the small muscles ofthe feet and hands. Arsenic reacts
with an essential thiol, inactivating one component ofthe pyruvate and alpha-glutarate
oxidase systems of enzymes. The site of toxicity is intracellular, causing axonal
changes [24,25], and fragmentation of myelin occurs after axonal degeneration takes
place [26]. Sensory fibers are affected before motor fibers, and distal fibers are
attacked before proximal portions [27]. Because arsenic strongly binds to tissue,
long-term chelation with penicillamine or 2,3-dimercapto-1-propanol is necessary to
eliminate ongoing toxic destruction of nerve fibers. Once axonal damage and second-
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ary myelin degeneration have occurred, there is little chance of regeneration and
clinical recovery [25].
The neuropathy associated with thallium exposure is progressive, beginning with
paresthesias of the extremities. Pain increases in severity as weakness and atrophy of
muscles appear. The skin of the trunk is also painful to touch, and muscles and nerves
are tender to pressure [28]. Animal experiments have demonstrated swollen neuronal
mitochondria, whereas the adjacent Schwann cells are not swollen [29]. Treatment for
thallium intoxication is geared toward facilitating its removal from tissues, especially
the mitochondrial membranes [29]. Inconsistent results have been found using the
various chelators, such as 2,3-dimercapto-1-prdpanol, penicillamine, edetate, and
dithiocarbamate [6]. Potassium chloride therapy is considered useful as an adjunct
because it exchanges potassium ions for thallium ions [30].
Neuropathy Due to Solvent Toxins
The neuropathy associated with MBK and n-hexane exposure is similar. Common to
both is the metabolite, 2,5-hexanedione. Initial symptoms are characterized by tingling
paresthesias in the feet and fingers, with loss of sensations to pinprick, temperature
discrimination, and touch. In severe cases, sensation losses have been observed as high
as the thigh and arm muscles, as well as the pelvic and hip girdles [31]. Vibration losses
have been noted over the feet and legs. Intrinsic muscles of the hands and feet are
affected. An outbreak of peripheral neuropathy from MBK exposure was observed in a
plant producing color-printed, plastic-coated, and laminated fabrics [32]. Cianchetti
and co-workers [33] observed toxic polyneuropathy in a group of Italian shoe industry
workers whose significant exposure was n-hexane. Since n-hexane is a constituent of
rubber cements, many glue sniffers have been observed to develop these symptoms.
Neuropathy Due to Mechanical Injury
Peripheral nerves can be mechanically damaged by lacerations or through compres-
sion, stretch, repeated trauma, and vibration [34]. Patients with acute trauma are
easily identified by the emergency of the event. It is the gradual development of
symptoms and signs of peripheral nerve dysfunction due to entrapment that can be
overlooked in a worker until function is impaired enough to affect productivity and
safety. This entrapment can occur as a result of repeated mechanical injury by forces
applied directly from the outside, as when holding a tool in a certain position. Subacute
and chronic syndromes of nerve dysfunction may also occur when a body part is
compressed or maintained in a certain position for long periods of time. Intermittent
and repeated blows to the areas where nerves lie close to the surface can produce
changes in the nerve fiber structure and function. Certain work situations and tasks are
more likely to result in nerve injury than others. Since the muscles of the upper
extremities are most frequently used during many tasks, several anatomic sites here
have greater potential for compression or entrapment. The ulnar nerve may become
entrapped in the hand or at the elbow; the median nerve at the wrist or in the forearm;
the radial nerve in the upper arm.
The median nerve can be compressed as it courses through the fascicles of the
pronator teres muscle in the forearm. In a job requiring repetitive movement of this
muscle, the muscle repeatedly contracts, the sublimis muscle edge tautens, and trauma
to the nerve can result. Job tasks requiring pronation with forceful finger flexion and
extension of the hands, as well as pinching motions of the fingers, have been associated
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with the pronator syndrome. Symptoms include numbness and dysesthesias of the
proximal forearm, the radial side of the palm, and the palmar side of the first three
digits and halfofthe fourth.
When the median nerve is compressed at the wrist as it travels with the flexor
tendons through the carpal tunnel, features of carpal tunnel syndrome develop. It is
known to develop in workers whose jobs involve repeated flexion and extension of the
wrist, particularly when flexion or extension is accompanied by pinching or gripping
tasks [35]. This motion squeezes the nerve between the overlying tendons and the
underlying flexor retinaculum. Carpal tunnel syndrome is characterized by bouts of
pain and paresthesias ofthe wrist and thefirst threedigits ofthe hand. Symptoms seem
to increase in severity at night. Severe sensory symptoms may precede thedevelopment
of muscle wasting or weakness, although weakness ofthe abductor pollicis brevis is an
important sign. The individual often has difficulty unscrewing a bottle top or turning a
key. Percussion of the median nerve at the wrists may create a sharp pain or tingling
sensation (Tinel's sign). Wrist flexion combined with thumb-finger opposition may
also create pain or tingling sensations (Phalen's sign).
It is important to recognize the possibility ofnerve compression or entrapment in the
work setting, since damage to the nerve is incomplete in the early stages, and an
adjustment in the use of tools or equipment may prevent further damage and allow
recovery. Changes in work-station design or in the design of hand-operated tools may
prevent injury in other workers. Furthermore, simple surgical release of entrapped
nerves, when necessary, will enable a worker to return to his or her previousjobwithout
further compromise of nerve function.
CONCLUSION
There are several categories of neurologic dysfunction that have been associated
with exposure to neurotoxic substances. It is easy to make a diagnosis of a solvent- or
metal-induced intoxication or entrapment neuropathy in a patient whose work history
and circumstances of exposure are known, and whose signs and symptoms are
consistent with those reported in the literature. However, when a patient is seen by a
physician and a neurologic diagnosis is to be made in the absence of a detailed work
history, the possible relationship to previous or current exposures may be overlooked.
The mechanisms for many neurotoxins are still obscure. Morphologic, histochemical,
and neurochemical studies of individual human cases and experimental animals,
coupled with epidemiologic studies of occupational groups, may eventually reveal the
characteristics ofeach toxin and how it interacts with biologic systems. On the basis of
such information, safety standards and environmental and biologic monitoring can be
implemented in the workplace to reduce the risk of undue absorption of known
potential intoxicants or exposures to potentially harmful physical factors. Physicians in
everyday clinical practice must be aware of the signs and symptoms associated with
exposure to possible neurotoxins and work methods. Occupational and environmental
circumstances must be explored when evaluating patients with neurologic disorders.
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